Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Sectoral/ Thematic median (252 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 29 Aug 2007 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 500 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | UTI - India Consumer Fund |
|---|---|
| 29 Aug 2007 | ₹100.00 |
| 29 Mar 2009 | ₹60.06 |
| 27 Oct 2010 | ₹122.71 |
| 27 May 2012 | ₹115.34 |
| 25 Dec 2013 | ₹146.36 |
| 26 Jul 2015 | ₹204.71 |
| 23 Feb 2017 | ₹216.95 |
| 23 Sep 2018 | ₹264.01 |
| 23 Apr 2020 | ₹232.39 |
| 21 Nov 2021 | ₹409.94 |
| 22 Jun 2023 | ₹413.76 |
| 19 Jan 2025 | ₹553.10 |
| 20 Aug 2026 | ₹595.92 |
| Metric | UTI · Regular NAV ₹59.83 Very High risk ★★☆☆☆ | Category median Sectoral/ Thematic · 252 funds |
|---|---|---|
| +1.03% | +5.83% | |
| +12.46% | +15.63% | |
| +10.33% | +13.23% | |
| +11.05% | +13.85% | |
| +9.86% | +12.26% | |
| +10.11% | — | |
| +12.31% | +15.60% | |
| +12.04% | +14.52% | |
| +11.48% | +13.74% | |
| Risk | ||
| 13.56% | 15.62% | |
| 0.44 | 0.43 | |
| 0.62 | 0.59 | |
| -56.92% | -23.65% | |
| Nifty 500 | — | |
| +0.67% | +3.42% | |
| 0.99 | 0.95 | |
| 106.0% | 105.9% | |
| 107.7% | 93.6% | |
| 2.41% | 2.39% | |
| ₹669.28Cr | ₹1,161Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹500 | — | |
| ₹5.00K | — | |
| 21% | 45% | |
| Vishal Chopda | — | |
| 29 Aug 2007 | — | |
| 43 | — | |
| 55.3% | — | |
| 1.9% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.